INVESTOR RELATION BACK NUMBER

SEARCH
2016.04.18
Notice regarding the agreement to enter into a consigned research and development contract with AMED (investigator-initiated joint clinical trial by multiple facilities for the use of (Hybrid Assistive Limb [HAL]-HN01) as a new medical device for rare brain/spinal cord diseases)
2016.02.12
2.5 times the net sales and 330 million decrease of Operating loss
2016.02.12
Announcement of Financial Results for the Nine Months Ended December 31, 2015
2016.02.12
Revision of forecast of consolidated financial results
2016.01.29
Notice on Robocare plan acknowledged eligible for Oita prefecture’s “regional resource utilized service creation support program”
2015.12.11
Notice on Reset of Conversion Price of Convertible Bonds due 2017
2015.12.03
Notice Concerning the Withdrawal of the Proceeds of the Convertible Bonds due 2017 from the Escrow Account
2015.11.16
2.6 Times the Net Sales for the Same Period Last Year
2015.11.13
Announcement of Financial Results for the Six Months Ended September 30, 2015
2015.10.13
Notice on Establishment of Sponsored Level I ADR Program in the United States
2015.08.17
1Q Quarterly consolidated financial results – Year-on-year comparison
2015.08.14
Announcement of Financial Results for the Three Months Ended June 31, 2015
2015.05.25
Announcement of Stock Split and Partial Revision of Articles of Incorporation
2015.04.22
Revision of forecast of consolidated financial results
2015.04.22
Improvement of work environment with robots in Kanagawa
2015.02.16
Supplemental data for the nine month ended December 31, 2014
2015.02.13
Announcement of Financial Results for the Nine Months Ended December 31, 2014
2014.12.04
Q&A concerning issuance of new shares and convertible bonds (vol.2)
2014.12.02
Q&A concerning issuance of new shares and convertible bonds
2014.11.27
Notice on Determination of the Terms of New Shares and Convertible Bonds due 2017 through the International Offering
BACK TO TOP